OLR1 and breast carcinoma: Kaplan–Meier survival plot reveal that patients with a high LOX-1 expression in tumor tissues had significantly shorter cancer-specific distant metastasis-free survival compared  to those with a low LOX-1 expression (p = 0.0039), confirming the relevance of LOX-1 expression in breast cancer progression and survival (Fig. 2a).